Peptide-based weight loss treatments have transformed obesity medicine. What was once limited to calorie counting, exercise programs, and bariatric surgery now includes a powerful category of medications that work with your body's hormonal signaling to reduce appetite, improve metabolism, and support sustainable weight loss.
But with multiple peptide options available — each targeting different pathways and producing different results — choosing the right one requires understanding how they work, what they cost, and who they are best suited for. This guide compares the leading weight loss peptides available through licensed clinics in 2026.
Semaglutide: The Standard-Bearer
Semaglutide is a GLP-1 receptor agonist and the most widely prescribed peptide for weight loss. It mimics the incretin hormone GLP-1, which your gut naturally releases after eating. By activating GLP-1 receptors in the brain and digestive system, semaglutide reduces appetite, increases satiety, slows gastric emptying, and improves blood sugar regulation.
In the landmark STEP clinical trial program, participants taking semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks. For a 220-pound individual, that translates to approximately 33 pounds. Notably, some participants lost significantly more, with about one-third achieving 20% or greater weight loss.
Semaglutide is available as brand-name Wegovy (FDA-approved for weight management) or as compounded semaglutide from licensed 503B pharmacies. Monthly cost ranges from $200 to $500 for compounded versions and $900 to $1,600 for brand-name without insurance. Read our full semaglutide clinics guide for detailed provider and pricing information.
Tirzepatide: The Dual-Action Contender
Tirzepatide takes the GLP-1 concept further by targeting two hormonal pathways simultaneously: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism appears to produce greater average weight loss than semaglutide alone.
In the SURMOUNT-1 trial, participants taking the highest dose of tirzepatide (15mg) lost an average of 22.5% of their body weight over 72 weeks. The SURMOUNT-4 trial demonstrated that patients who discontinued tirzepatide regained approximately two-thirds of their lost weight within one year, underscoring that these medications work best as ongoing therapy rather than short-term interventions.
Tirzepatide is marketed as Mounjaro (for Type 2 diabetes) and Zepbound (for weight management). Compounded versions are also available. Pricing is comparable to semaglutide: $200 to $500 monthly for compounded, $900+ for brand-name.
CJC-1295 / Ipamorelin: The Growth Hormone Approach
While GLP-1 medications target appetite directly, growth hormone-releasing peptides take an indirect approach to body composition. CJC-1295 and Ipamorelin stimulate the pituitary gland to produce more growth hormone, which in turn promotes fat metabolism, lean muscle preservation, and improved metabolic rate.
The weight loss from growth hormone peptides is generally more modest than GLP-1 medications — typically 5 to 10% of body weight over 6 to 12 months. However, the composition of that weight loss is often favorable: patients tend to lose fat while preserving or gaining lean muscle, which is not always the case with GLP-1 medications where some muscle loss can occur alongside fat loss.
CJC-1295/Ipamorelin is often prescribed alongside a GLP-1 medication to offset potential muscle loss, or as a standalone option for patients who want modest body composition improvement without the GI side effects of semaglutide. Monthly cost: $200 to $450.
Comparison Table
| Peptide | Avg. Weight Loss | Monthly Cost | Best For |
|---|---|---|---|
| Semaglutide | ~15% body weight | $200–$500 | Significant weight loss, appetite control |
| Tirzepatide | ~22% body weight | $200–$500 | Maximum weight loss, dual mechanism |
| CJC-1295/Ipamorelin | 5–10% body weight | $200–$450 | Body recomposition, muscle preservation |
| AOD-9604 | Modest (limited data) | $150–$350 | Fat metabolism support, fewer side effects |
Which Peptide Is Right for You?
The best weight loss peptide depends on your individual circumstances. Semaglutide or tirzepatide are typically first-line options for patients with a BMI over 30 or BMI over 27 with weight-related health conditions who need significant, medically supervised weight loss. CJC-1295/Ipamorelin may be better suited for patients seeking moderate body composition changes with simultaneous benefits for sleep, recovery, and skin quality. Combination approaches are increasingly common, with physicians pairing a GLP-1 medication with growth hormone peptides to maximize fat loss while preserving muscle.
The most important step is consulting with a qualified physician who can evaluate your health profile, discuss realistic expectations, and design a protocol matched to your goals. For a complete primer on finding the right provider, read how peptide doctors work and explore our peptide therapy clinic directory.
Find a Weight Loss Peptide Provider
Browse verified clinics offering semaglutide, tirzepatide, and other weight management peptides.
Search the DirectoryMedical Disclaimer: Weight loss results vary by individual. Peptide therapy for weight management requires medical supervision. This content is for informational purposes only. Last reviewed: April 2026.